Search Results 341-350 of 18877 for Neutrophil

1. An Extension Study to Evaluate the Long-Term Safety and Tolerability of NEOD001 for Treatment of People with Light Chain Amyloidosis - Mayo Clinic

   Absolute neutrophil count (ANC) ≥1.0 ×109/L; Platelet count ≥75 × 109/L; Hemoglobin ≥9 g/dL; Total bilirubin ≤2 times the upper limit of normal (× ULN) ...

2. A Study to Evaluate Fisetin to Alleviate Dysfunction and Inflammation in COVID-19 Subjects - Mayo Clinic

   L (≤ 40 x 10^9/L); absolute neutrophil count ≤1 x 10^9/L; lymphocyte count < 0.3 x 10^9/L at screening or as per clinical judgment. 6. Unstable (as per ...

3. IL-2 plus FOLFOX and Nivolumab for Treatment of Peritoneal Metastases - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1000/mm^3;; Platelet count ≥ 75,000/mm^3;; Total bilirubin ≤ 1.5 x ULN;; Alanine aminotransferase (ALT) AND aspartate ...

4. Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients with Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorder - Mayo Clinic

   Anticancer agents not known to be myelosuppressive (e.g., not associated with reduced platelet or absolute neutrophil counts [ANC]): ≥ 7 days after the ...

5. Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy - Mayo Clinic

   Absolute neutrophil count >= 1000/mm^3;; Platelet count >= 30,000/mm^3;; Serum creatinine =< 1.5 x upper limit of normal (ULN);; Total bilirubin =< 1.5 mg/dL ...

6. Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer - Mayo Clinic

   Absolute neutrophil count > 2,000/mm3; Platelets > 100,000/ mm3; Hemoglobin > 8.0 gm/dL; Total bilirubin within normal limits. Ejection fraction by MUGA scan or ...

7. A Study Comparing Gemcitabine with or without AZD 1775 in Treating Patients with Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

   Absolute neutrophil count ≥ 1,500/mcL; Platelets ≥ 100,000/mcL; Hemoglobin ≥ 90 g/L. Blood transfusions are allowed at any time during the screening ...

8. An Expanded Access Study of Iniparib Combined with Gemcitabine and Carboplatin for the Treatment of Breast Cancer - Mayo Clinic

   Participation eligibility · Absolute neutrophil count (ANC) ≥1500/mm3 · Platelets ≥100,000/dL · Hemoglobin ≥9 g/dL · Bilirubin ≤1.5 mg/dL · Serum creatinine ≤ ...

9. Chemoradiation With or Without Atezolizumab in Treating Patients With Limited Stage Small Cell Lung Cancer - Mayo Clinic

   Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 within 30 days prior to registration. Absolute neutrophil count (ANC) ≥ 1, 500/cells/mm ...

10. A Study to Evaluate the Safety of bb2121 in Subjects With High Risk, Newly Diagnosed Multiple Myeloma (NDMM) (KarMMa-4) - Mayo Clinic

    Participation eligibility · Absolute neutrophil count < 1,000/μL; · Platelet count < 50,000 mm^3; · Hemoglobin < 8 g/dL (< 4.9 mmol/L); · Serum creatinine clearance ...